东星医疗：关于使用部分闲置募集资金和自有资金进行现金管理的公告
Jiangsu Canopus Wisdom Medical Technology Jiangsu Canopus Wisdom Medical Technology (SZ:301290) Zheng Quan Ri Bao·2025-12-04 07:49

Group 1 - The company, Dongxing Medical, announced plans to utilize up to RMB 670 million of idle raised funds (including oversubscription funds) and up to RMB 600 million of idle self-owned funds for cash management [2] - The announced amounts and usage period can be rolled over within 12 months from the date of approval by the company's shareholders' meeting [2]